TSANZ SIG Orals: OLIV (2)
Tracks
Track 5
Tuesday, March 26, 2024 |
10:30 AM - 12:00 PM |
Meeting Room 6 |
Speaker
Dr Hui Li Ang
Basic Physician Trainee
Royal Melbourne Hospital
Dr Andre Chobanian
Junior Medical Officer
University of Sydney
Describing the idiopathic inflammatory myopathy population in the Australasian Interstitial lung disease registry
10:45 AM - 11:00 AMBiography
Andre Chobanian will be starting as a junior medical officer in 2024. He has a keen interest in respiratory medicine and passion for research. He has worked closely with Dr Matthew Parker (Rheumatology) and Prof Tamera Corte (Respiratory) at RPA to investigate the idiopathic inflammatory myopathy population in the AILDR.
Ms Carly Barton
Clinical Nurse Specialist
Royal Prince Alfred Hospital
The Registry for Better Understanding of ILD (RE-BUILD) smartphone application pilot study
11:00 AM - 11:15 AMBiography
Carly is a Clinical Nurse Specialist working in Interstitial Lung Disease Clinical Trials at Royal Prince Alfred Hospital. She is interested in research and increasing health equity in vulnerable populations.
Dr Wenying Lu
Postdoctoral Researcher
University of Tasmania
Increased PAFR and ICAM-1 in IPF: implications for microbial pathogenesis
11:15 AM - 11:30 AMBiography
Dr Lu is a Postdoctoral Researcher with the Respiratory Translational Research Group at University of Tasmania. Her research pursuits involve gaining insights into the pathogenesis of chronic respiratory diseases, including COPD, IPF, lung cancer, and Asthma-COPD overlap (ACO), also actively examining the impact of vaping on human lung cellular changes.
Dr John Mackintosh
Respiratory and Lung Transplant Physician
The Prince Charles Hospital
Telomere Length in Australian Adults with Pulmonary Fibrosis
11:30 AM - 11:45 AMBiography
John is a respiratory and lung transplant physician at The Prince Charles Hospital. John completed a clinical fellowship in interstitial lung disease at the Royal Brompton Hospital in London. Whilst at the Royal Brompton Hospital John developed a keen interest in familial pulmonary fibrosis and the genetics of interstitial lung disease.
Miss Olivia N Young
PhD Candidate
Monash University
AT2R agonist compound 21 inhibits ex vivo IPF fibrogenesis in human precision cut lung slices
11:45 AM - 12:00 PMBiography
Olivia Young is a PhD student in the department of Pharmacology at Monash, currently investigating the anti-fibrotic potential of angiotensin type 2 receptor agonists in the treatment of IPF.
Assoc Prof Nicole Goh
Respiratory And Sleep Physician
Austin Hospital
Chairperson
10:30 AM - 12:00 PMBiography
Nicole Goh is a Respiratory Physician with an interest in interstitial lung disease. She is the Director of ILD services at the Austin Hospital in Melbourne and is actively involved with the Centre of Research Excellence in Pulmonary Fibrosis.
Dr Robert Sheehy
Respiratory & Sleep Physician
Princess Alexandra Hospital
Chairperson
10:30 AM - 12:00 PMBiography
Dr Robert Sheehy is a Respiratory & Sleep Physician with a clinical and research interest in interstitial lung disease. He is a Staff Specialist at the Princess Alexandra Hospital in Brisbane.